Literature DB >> 8653866

Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives.

K Kario1, N Kanai, K Saito, N Nago, T Matsuo, K Shimada.   

Abstract

BACKGROUND: The ACE insertion/deletion (I/D) polymorphism is reported to be associated with myocardial infarction in both whites and Japanese. However, there have been no reports on the association of this polymorphism with stroke in each race. Furthermore, there are some racial differences in the demographics of cardiovascular disease. In Japanese, stroke (especially that which occurs in preexisting hypertension) is more common and coronary artery disease much less common than in whites. We propose that the ACE I/D polymorphism might be associated with hypertensive cerebrovascular disease in Japanese. METHODS AND
RESULTS: To study the association between the ACE I/D polymorphism and hypertensive cerebrovascular disease, we identified the ACE I/D genotype in 228 hypertensive and 104 normotensive Japanese subjects. Compared with its frequency (0.31) in the 90 hypertensives without lacunae detected by magnetic resonance imaging, the ACE*D allele frequency was significantly higher (0.47; P<.001) in the 138 hypertensives with silent or clinically overt ischemic stroke, whereas there was no significant difference between its frequency in hypertensives without lacunae and in 104 normotensive control subjects (0.34). The positive association between the ACE I/D genotype and ischemic stroke in hypertensive patients was independent of other risk factors.
CONCLUSIONS: We found a positive association between the ACE*D allele and ischemic stroke in Japanese hypertensives in our study. The ACE*D allele may be an independent risk factor for the development of cerebrovascular disease in hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8653866     DOI: 10.1161/01.cir.93.9.1630

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

1.  Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion.

Authors:  Tadashi Suehiro; Tatsuhito Morita; Mari Inoue; Yoshitaka Kumon; Yukio Ikeda; Kozo Hashimoto
Journal:  Hum Genet       Date:  2004-05-26       Impact factor: 4.132

2.  Angiotensin-I converting enzyme gene and I/D polymorphism distribution in the Greek population and a comparison with other European populations.

Authors:  Sekerli Eleni; Katsanidis Dimitrios; Papadopoulou Vaya; Makedou Areti; Vavatsi Norma; Gatzola Magdalini
Journal:  J Genet       Date:  2008-04       Impact factor: 1.166

3.  Meta-analysis of the ACE gene in ischaemic stroke.

Authors:  P Sharma
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

Review 4.  Cerebral white matter lesions in essential hypertension.

Authors:  C Sierra
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

5.  Genetic susceptibility to ischemic cerebrovascular disease in Koreans.

Authors:  Jae-Young Um; Nyeon-Hyoung An; Sang-Hun Kim; Kang-Min Lee; Yo-Sik Kim; Hyuk Jang; Kwang-Ho Cho; Byung-Soon Moon; Hyung-Min Kim
Journal:  J Mol Neurosci       Date:  2003-02       Impact factor: 3.444

6.  Polymorphism of the angiotensin-converting enzyme gene in patients with cerebral infarction in Koreans.

Authors:  J Y Um; H J Kim; T J Choi; C S Jin; S T Park; K C Lee; H S Rhee; K M Lee; Y M Lee; H M Kim; N H An; J J Kim
Journal:  J Mol Neurosci       Date:  2001-12       Impact factor: 3.444

7.  ACE and AT1R gene polymorphisms and hypertension in Indian population.

Authors:  T F Ashavaid; K K Shalia; K G Nair; J J Dalal
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

8.  Angiotensin-Converting Enzyme Gene Polymorphism and Plasminogen Activator Inhibitor 1 Levels in Subjects with Cerebral Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-07       Impact factor: 2.300

9.  Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer's disease and vascular dementia.

Authors:  H K Wang; H C Fung; W C Hsu; Y R Wu; J C Lin; L S Ro; K H Chang; F J Hwu; Y Hsu; S Y Huang; G J Lee-Chen; C M Chen
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

10.  Angiotensin-converting enzyme insertion/deletion polymorphism contributes to ischemic stroke risk: a meta-analysis of 50 case-control studies.

Authors:  Zhizhong Zhang; Gelin Xu; Dezhi Liu; Xinying Fan; Wusheng Zhu; Xinfeng Liu
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.